Published by Josh White on 7th November 2017
(ShareCast News) - Healthcare intellectual property commercialisation group NetScientific noted on Tuesday that its portfolio company, Vortex BioSciences, has announced its first direct commercial sale of its VTX-1 Liquid Biopsy System - a fully automated benchtop system for collecting intact circulating tumour cells (CTCs).